MARKET

SPNE

SPNE

Seaspine Hldgs Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.44
+0.13
+1.56%
After Hours: 8.44 0 0.00% 16:00 05/26 EDT
OPEN
8.43
PREV CLOSE
8.31
HIGH
8.50
LOW
8.15
VOLUME
234.83K
TURNOVER
0
52 WEEK HIGH
21.98
52 WEEK LOW
8.00
MARKET CAP
310.59M
P/E (TTM)
-5.2550
1D
5D
1M
3M
1Y
5Y
Is SeaSpine Holdings (NASDAQ:SPNE) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Simply Wall St. · 4d ago
SeaSpine Holdings Q1 EPS $(0.45) Misses $(0.35) Estimate, Sales $50.69M Beat $48.96M Estimate; Raises FY22 Sales Guidance From $226M-$230M To $231M-$235M vs $228.4M Est.
SeaSpine Holdings (NASDAQ:SPNE) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.35) by 28.57 percent. This is a 2.17 percent increase over losses of $(0.46) per share
Benzinga · 05/03 21:06
SeaSpine Holdings: Q1 Earnings Insights
SeaSpine Holdings (NASDAQ:SPNE) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Benzinga · 05/03 20:48
BRIEF-Seaspine Reports Q1 Results
reuters.com · 05/03 20:37
SeaSpine GAAP EPS of -$0.45 misses by $0.09, revenue of $50.69M beats by $1.73M
SeaSpine press release (NASDAQ:SPNE): Q1 GAAP EPS of -$0.45 misses by $0.09. Revenue of $50.69M (+20.8% Y/Y) beats by $1.73M.
Seekingalpha · 05/03 20:31
-- Earnings Flash (SPNE) SEASPINE HOLDINGS CORPORATION Reports Q1 Revenue $50.7M, vs. Street Est of $49M
MT Newswires · 05/03 16:34
SeaSpine® Announces Full Commercial Launch of OsteoTorrent™ DBM Product Families
OsteoTorrent DBM SeaSpine® Announces Full Commercial Launch of OsteoTorrent™ DBM Product Families CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solut...
GlobeNewswire · 05/02 20:05
Preview: SeaSpine Holdings's Earnings
SeaSpine Holdings (NASDAQ:SPNE) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that SeaSpine Holdings will report an earnings per share (EPS) of $-0....
Benzinga · 05/02 16:16
More
No Data
Learn about the latest financial forecast of SPNE. Analyze the recent business situations of Seaspine Hldgs Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
50.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average SPNE stock price target is 21.16 with a high estimate of 26.25 and a low estimate of 16.00.
High26.25
Average21.16
Low16.00
Current 8.44
EPS
Actual
Estimate
-0.42-0.31-0.21-0.10
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 141
Institutional Holdings: 32.89M
% Owned: 89.37%
Shares Outstanding: 36.80M
TypeInstitutionsShares
Increased
28
1.15M
New
9
682.07K
Decreased
31
791.22K
Sold Out
10
623.02K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.54%
Healthcare Equipment & Supplies
+0.56%
Key Executives
Non-Executive Chairman/Independent Director
Kirtley Stephenson
President/Chief Executive Officer/Director
Keith Valentine
Chief Financial Officer/Chief Operating Officer/Senior Vice President
John Bostjancic
Corporate Executive
Beau Standish
Senior Vice President/General Counsel/Secretary
Patrick Keran
Senior Vice President/Director of Human Resources
Hollis Winkler
Senior Vice President
Dennis Cirino
Senior Vice President
Tyler Lipschultz
Chief Scientific Officer
Frank Vizesi
Vice President/Director of Sales
John Winge
Vice President
Shaeffer Bannigan
Lead Director/Independent Director
Stuart Essig
Independent Director
Keith Bradley
Independent Director
Michael Fekete
Independent Director
Renee Gaeta
Independent Director
John Henneman
Independent Director
Shweta Maniar
Independent Director
Angela Steinway
No Data
No Data
About SPNE
SeaSpine Holdings Corporation is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company offers a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine. The Company's product categories include orthobiologics and spinal implants and enabling technologies. Orthobiologics products consist of a range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following surgery. The spinal implants and enabling technology portfolio consists of a line of products, including minimally invasive surgery, complex spine, deformity and degenerative procedures as well as a surgical navigation system.

Webull offers kinds of SeaSpine Holdings Corp stock information, including NASDAQ:SPNE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPNE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SPNE stock methods without spending real money on the virtual paper trading platform.